Archive Category: Green Zone Fortunes Updates

This week, we discussed three stocks in the biotech sector.

Have you ever had a close look at a stock on a chart and gotten a “feel” for where it would go next?

This week, we discussed the three stocks in the consumer discretionary sector.

I know I reached out earlier to find out how you did with the profits we locked in on a portion of our play on Twist Bioscience Corp. (Nasdaq: TWST) yesterday, so forgive me if some of the discussion on this trade is redundant.

I originally recommended buying shares of Twist Bioscience Corp. (Nasdaq: TWST) in the May issue of Green Zone Fortunes because I thought its focus on syntheticDNA gave it a uniquely advantageous position in the broader genomics industry, which I’ve said before is “the future of everything” in the health care sector.